Study summary · research use only
[The effect of thymogen on the state of immunity in destructive pulmonary tuberculosis]
Plain-language summary
Paraphrased from the published abstract below — not a verdict on whether anything works.
This brief article describes timoguen (thymogen) as an immunocorrector in patients with destructive forms of pulmonary tuberculosis. The authors state that it stimulated the T-cell component of immunity, increased tolerance for etiotropic drugs, and was associated with disappearance of intoxication syndromes, closure of decomposition cavities, and cessation of bacterial discharge. The article describes an immunostimulation schedule of 2 courses (a 1% solution given as 1 ml injections, number 10, every 2 days, during the 2nd and 4th months of the treatment course). The abstract is short and presents claims without detailed quantitative outcome data. Patients were human; no comparison group or statistics are described.
Abstract
The article shows that the immunocorrector timoguen stimulates T-cell link in patients with destructive forms of pulmonary tuberculosis, increases tolerance for ethiotropics, makes intoxication syndromes disappear and heals decomposition cavities and stops the bacteria discharge. It recommends 2 courses of timoguen immunostimulation (1% solution by 1 ml injection N 10 in 2 days for 2 and 4 mouths' treatment course).
pepmg summarizes the peer-reviewed literature and links to every source — it sells nothing, ships nothing, and gives no medical, dosing, or human-use guidance. Don't just trust this summary: follow the citation to its source and read it yourself. Research use only.